food4thought Wednesday, 07/29/20 02:40:29 PM Re: A-Gee10 post# 2227 Post # of 2727 That’s the right way to look at it. At some point the share price will be determined by the fundamentals with forward earnings and growth multiples factoring into the MC. I see both Curaleaf and Trulieve as solid value and growth plays moving into 2021-2022. Green thumb shouldn’t be far behind. They should each be profitable by then, hopefully off the OTC with Federal legislation approval and building an institutional investor base. The Fed will provide the launch pad. Institutions will want this action.